Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Sorry, im new to Labs...
View:
Post by MissStock111 on Nov 21, 2020 8:11am

Sorry, im new to Labs...

Can u explain me why revenue are down so much this quarter compare to the 2019 one? Will it go back to previous revenu or is it planned to stay that low? I mean revenue of 5M and cost of sale of 15M? 

i like their fin sheet, no debt, same cash on hands... but still need to get revenu coming back...

tell me more please

Comment by lscfa on Nov 21, 2020 1:24pm
Mgmt needs to provide guidance. Analyst estimates are all over the map.....     2021 Revenue 2021 eps no. of analysts 5 5 High 175M $0.050 low 40.5M ($0 ...more  
Comment by Lemoyne on Nov 21, 2020 8:31pm
As much as I think LABS will improve over long term, principally due to german/STADA, Australia and other pharma deals, I think next year will disappoint people hoping for a quick buck or people that got in during 2019 high. Reality is, german medical market is not even worth 300M USD, maybe not even 250M USD in 2020. Considering this, it is not realistic to expect LABS making huge money next ...more  
Comment by cyberman on Nov 21, 2020 11:03pm
been in and out a few times, overall at a small loss but willing to take my chances at this price, and chase it down some more if i have too ! realistically we are one good PR away from a nice bounce, good luck.
Comment by flad101 on Nov 21, 2020 6:22pm
If you want to lose money listen to iscfa.  If you want to make money do the opposite.  Beware of him.  He is a paid pumper.  He will not give you any true insight and will steer ya wrong.  Good luck
Comment by stealthct on Nov 23, 2020 12:36pm
Collections Agencies are calling ISCFA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities